Phoenix Biotech Acquisition Corp.
PBAX · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 |
| Gross Profit | $0 | $255 | $0 |
| % Margin | – | – | – |
| R&D Expenses | $7,080 | $0 | $0 |
| G&A Expenses | $9,118 | $2,841 | $0 |
| SG&A Expenses | $9,118 | $2,841 | $252 |
| Sales & Mktg Exp. | $0 | $0 | $251 |
| Other Operating Expenses | $0 | $64 | -$80 |
| Operating Expenses | $16,198 | $2,905 | $332 |
| Operating Income | -$16,198 | -$3 | -$332 |
| % Margin | – | – | – |
| Other Income/Exp. Net | $5,109 | $3 | -$0 |
| Pre-Tax Income | -$11,089 | -$69 | -$332 |
| Tax Expense | $0 | $599 | -$17 |
| Net Income | -$11,089 | -$668 | -$316 |
| % Margin | – | – | – |
| EPS | -0.22 | -0.01 | -0.005 |
| % Growth | -2,122.2% | -115.2% | – |
| EPS Diluted | -0.22 | -0.01 | -0.005 |
| Weighted Avg Shares Out | 49,676 | 67,478 | 68,944 |
| Weighted Avg Shares Out Dil | 49,676 | 67,478 | 68,944 |
| Supplemental Information | – | – | – |
| Interest Income | $0 | $2,837 | $0 |
| Interest Expense | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | -$5,674 | $237 |
| EBITDA | -$16,198 | -$5,742 | -$332 |
| % Margin | – | – | – |